由于其广泛的接触表面和孔隙率,在快速溶解药物输送系统中使用静电纺丝纤维可加速活性物质的释放。琥珀酸舒马曲坦 (SS) 是一种抗偏头痛药物,对人类健康具有有益和已证实的作用,但其存在苦味、口服吸收低和半衰期短等缺点,限制了其在药物体系中的应用。在这项工作中,开发了新的纳米纤维垫以增加口服吸收并提高药物的功效。加载 0.15% SS、0.5% SS 和 1% SS 的平均纤维直径分别为 313.29 ± 31 nm、373.37 ± 29 nm 和 453 ± 42 nm。通过在静电纺丝溶液中添加琥珀酸舒马普坦,纤维的粘度、导电性和拉伸强度增加,但 pH 值降低。傅立叶变换红外 (FT-IR)、差示扫描量热法 (DSC) 和 X 射线衍射 (XRD) 分析证实药物与聚合物膜之间不存在相互作用。负载舒马普坦的可溶性大豆多糖 (SSPS) 纳米纤维垫获得了快速释放速率,其中 95% 的舒马普坦在 20 秒内释放。细胞毒性评估表明,没有一种纳米纤维对成纤维细胞具有毒性。总体而言,舒马曲坦可以很好地负载在SSPS纳米纤维中,并在口腔中更快地释放,这将有效提高治疗效果的起效,减少偏头痛。负载舒马普坦的可溶性大豆多糖 (SSPS) 纳米纤维垫获得了快速释放速率,其中 95% 的舒马普坦在 20 秒内释放。细胞毒性评估表明,没有一种纳米纤维对成纤维细胞具有毒性。总体而言,舒马曲坦可以很好地负载在SSPS纳米纤维中,并在口腔中更快地释放,这将有效提高治疗效果的起效,减少偏头痛。负载舒马普坦的可溶性大豆多糖 (SSPS) 纳米纤维垫获得了快速释放速率,其中 95% 的舒马普坦在 20 秒内释放。细胞毒性评估表明,没有一种纳米纤维对成纤维细胞具有毒性。总体而言,舒马曲坦可以很好地负载在SSPS纳米纤维中,并在口腔中更快地释放,这将有效提高治疗效果的起效,减少偏头痛。
"点击查看英文标题和摘要"
Development and characterization of sumatriptan-loaded soy bean polysaccharide nanofiber using electrospinning technique
The use of electrospinning fibers in rapid-dissolving drug delivery systems accelerates the release of the active substance due to their extensive contact surface and porosity. Sumatriptan succinate (SS), an antimigraine drug has beneficial and proven effects on human health, but it has some shortcomings such as bitter-taste, low oral absorption and low half-life that limit its application in pharmaceutical systems. In this work, the new nanofiber mats were developed to increase oral absorption and improve the efficacy of drug. The mean fiber diameters were 313.29 ± 31 nm, 373.37 ± 29 nm and 453 ± 42 nm for those loaded by 0.15% SS, 0.5% SS and 1% SS, respectively. By adding sumatriptan succinate to the electrospinning solution, viscosity, electrical conductivity and tensile strength in fibers increased, but pH decreased. Fourier transform infrared (FT-IR), differential scanning calorimetry (DSC) and X-Ray diffraction (XRD) analyses confirmed the absence of interactions between drug and polymer membrane. A fast release rate was obtained for sumatriptan-loaded soluble soy bean polysaccharide (SSPS) nanofiber mats, where 95% of the sumatriptan released within 20 s. Cytotoxicity evaluation revealed that none of the nanofibers had toxic properties on the fibroblasts cells. Overall, sumatriptan can be loaded well in SSPS nanofibers and released more quickly in oral space, which will be effective in improving the onset of therapeutic effects and reducing migraine headaches.